Pharma & healthcare

Shaping the Future of Pharmaceutical Manufacturing with Smart Solutions.

Pharmaceutical Lab Operator

Explore our products

Markets

Our portfolio includes single units, modular systems and complete production lines for powder processing, oral solid dosage forms, parenterals, liquids, semi-solids and nutraceuticals. So, wherever you are, whatever the scale of your operation or indication, we have the capability to make your concept a reality, optimize your process, improve your production efficiency and deliver the ongoing support to make your business a success.

Test before you invest.

Committed to advancing our customers’ research and development activities, GEA’s pharmaceutical technology test centers provide global technical support and know-how to the pharmaceutical industry.
These centers of excellence give you access to a full range of test facilities and teams of experts, all of whom work closely with our customers to optimize processes and evaluate their products, enabling them to achieve their process and production goals in a cost-effective way.

Workers working at Hovione

Advancing continuous pharmaceutical manufacturing

GEA and partners innovate flexible continuous processing technologies, transforming pharmaceutical development and manufacturing for a modernized future.

biopharma industry

Os separadores de perfusão aceleram os processos biofarmacêuticos

Pequenas empresas de fabricação de produtos biofarmacêuticos geralmente são a força motriz por trás da proliferação de tratamentos médicos inovadores. A GEA está revolucionando os recursos de colheita de células para esses fabricantes com separadores de perfusão que permitem o processamento contínuo com eficiência otimizada. Pela primeira vez, os separadores de centrífuga de discos adaptados foram transformados em máquinas compactas de uso único, economizando espaço, mão de obra e esforço e, ao mesmo tempo, abrindo caminho para o aumento e a aceleração da produção.

Downloads

Insights da GEA

GEA Globe

GEA reports profitable growth for 2025 and expects accelerated revenue growth

GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.

This photo shows an aerial view of the SmartParc factory

How SmartParc is rewriting the rules of food production

Thanks to a new SmartParc manufacturing site, food processors in the U.K. are cutting their running costs and emissions. With GEA heating and cooling technology at its core, this collaborative production model demonstrates how innovation is accelerating the industry’s net-zero ambitions.

Sushi dish made with the ingredient Bioalbumen®, an egg-white protein (ovalbumin) (Onego Bio)

O playground da ciência dos alimentos

"Cozinhar ovos é como cozinhar cerveja". É o tipo de comparação que faz você sorrir - depois, dá um clique: Algo complexo de repente parece simples. Por meio desse filme pessoal, ambientado no coração agrícola dos EUA, exploramos a fermentação de precisão e o trabalho real necessário para transformar uma ideia em alimentos.

Receba notícias da GEA

Mantenha-se atualizado com as inovações e histórias da GEA, se registrando para receber notícias sobre a GEA.

Entre em contato

Estamos aqui para ajudar! Com apenas poucos detalhes poderemos responder à sua pergunta.